CSI Market
Sign In | Register

Cytek Biosciences Inc (CTKB) Annual Balance Sheets

Annual · GAAP · USD millions
Access CTKB quarterly Balance Sheets →
Balance sheet data covering Cytek Biosciences Inc–Dec 31 2021 offers a view into how Dec 31 2025's financial position has changed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent90.85
Marketable Securities, Total MA170.68
Cash & Short-term Investments260.00
Accounts receivable62.51
Inventories48.43
Other Current Assets0.00
Prepaid Expense And Other Assets Current19.53
Total Current Assets392.00
Equipment/Property/Plant Net18.01
Goodwill net16.70
Intangible Assets16.82
Deferred Tax Assets, Deferred Income0.00
Other Assets, Noncurrent18.02
Restricted Cash Current-
Operating Lease Right Of Use Asset11.32
Total Assets461.54
Liabilities
Accounts Payable, Trade, Current6.41
Accrued Liabilities, Current25.91
Other Liabilities, Current16.98
Deferred Revenue, Current DE28.50
Total Current Liabilities77.80
Long-term debt0.53
Total Long-term Debt0.53
Estimated Litigation Liability, Noncurrent LI6.79
Deferred Revenue, Noncurrent DE18.34
Other liabilities, Noncurrent2.31
Operating Lease Liability Noncurrent14.04
Total Liabilities119.80
Stockholders' Equity
Noncontrolling Interest In Consolidated Subsidiary-
Common Stock Value0.13
Additional Paid In Capital Common Stock441.11
Retained Earnings / Accumulated Deficit-101.74
Other Equity2.24
Common Stockholder's Equity341.74
Total Stockholder's Equity341.74
Liabilities & Stockholder's Equity461.54
4 historic quarters locked

Sign in to unlock the full Cytek Biosciences Inc balance sheet history.

Sign In Create Free Account

About Cytek Biosciences Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: ctkb-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-012352

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.